靶向抗癌-话题@MedSci - 梅斯（MedSci）

#靶向抗癌#

15篇内容 | 732人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1819825, encodeId=5ce4181982521, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=Transl Res：王慧和刘宁宁团队发现靶向抗癌药物能增强抗真菌作用, objectType=article, longId=737079, objectId=cc3be37079e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc3be37079e2, replyNumber=0, likeNumber=122, createdTime=2022-11-20, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc3be37079e2, moduleTitle=Transl Res：王慧和刘宁宁团队发现靶向抗癌药物能增强抗真菌作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cc3be37079e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819824, encodeId=a982181982407, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=National Science Review ：突破 | 刘红科/赵劲/郭子建提出的新策略成功实现了肿瘤内制造靶向抗癌药物, objectType=article, longId=205073, objectId=f81c2050e390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f81c2050e390, replyNumber=0, likeNumber=76, createdTime=2021-11-07, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f81c2050e390, moduleTitle=National Science Review ：突破 | 刘红科/赵劲/郭子建提出的新策略成功实现了肿瘤内制造靶向抗癌药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f81c2050e390)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819823, encodeId=bc421819823f8, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=诺华的新型口服CDK4/6靶向抗癌药Kisqali喜获NICE推荐，用作二线治疗晚期乳腺癌, objectType=article, longId=175681, objectId=3cfe1e5681e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cfe1e5681e2, replyNumber=0, likeNumber=70, createdTime=2019-10-27, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cfe1e5681e2, moduleTitle=诺华的新型口服CDK4/6靶向抗癌药Kisqali喜获NICE推荐，用作二线治疗晚期乳腺癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3cfe1e5681e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819822, encodeId=fb9718198225c, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=JAMA Oncol：靶向抗癌药究竟对哪些癌症患者有效，一测便知！, objectType=article, longId=118110, objectId=a82011811056, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a82011811056, replyNumber=0, likeNumber=106, createdTime=2018-08-22, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a82011811056, moduleTitle=JAMA Oncol：靶向抗癌药究竟对哪些癌症患者有效，一测便知！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a82011811056)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819821, encodeId=1096181982124, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=J Am Acad Dermatol：使用靶向抗癌药物能促进患者的色素改变（Meta分析）, objectType=article, longId=113400, objectId=43e411340026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43e411340026, replyNumber=0, likeNumber=0, createdTime=2018-07-19, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43e411340026, moduleTitle=J Am Acad Dermatol：使用靶向抗癌药物能促进患者的色素改变（Meta分析）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=43e411340026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819820, encodeId=46341819820ab, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=肝癌福音！美国FDA授予拜耳靶向抗癌药Stivarga优先审查资格，二线治疗晚期肝细胞癌, objectType=article, longId=86806, objectId=74ba86806dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74ba86806dc, replyNumber=0, likeNumber=64, createdTime=2017-12-05, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74ba86806dc, moduleTitle=肝癌福音！美国FDA授予拜耳靶向抗癌药Stivarga优先审查资格，二线治疗晚期肝细胞癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=74ba86806dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819819, encodeId=44ce181981977, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=重磅！诺华新型靶向抗癌药Zykadia一线治疗晚期ALK+肺癌III期临床获得成功，辉瑞霸主地位将不保, objectType=article, longId=78707, objectId=88a4e870731, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88a4e870731, replyNumber=0, likeNumber=80, createdTime=2017-01-30, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88a4e870731, moduleTitle=重磅！诺华新型靶向抗癌药Zykadia一线治疗晚期ALK+肺癌III期临床获得成功，辉瑞霸主地位将不保, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=88a4e870731)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819818, encodeId=91f21819818bd, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=精准医疗典范：欧盟批准辉瑞靶向抗癌药Xalkori治疗ROS1阳性非小细胞肺癌（NSCLC）, objectType=article, longId=76572, objectId=8bfbe657216, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bfbe657216, replyNumber=0, likeNumber=72, createdTime=2016-11-12, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bfbe657216, moduleTitle=精准医疗典范：欧盟批准辉瑞靶向抗癌药Xalkori治疗ROS1阳性非小细胞肺癌（NSCLC）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8bfbe657216)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819817, encodeId=e8f5181981e74, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=喜讯！辉瑞口服靶向抗癌药Xalkori（克唑替尼）获英国NICE推荐，一线治疗ALK阳性肺癌, objectType=article, longId=75774, objectId=c8c4e5774d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8c4e5774d2, replyNumber=0, likeNumber=99, createdTime=2017-03-24, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8c4e5774d2, moduleTitle=喜讯！辉瑞口服靶向抗癌药Xalkori（克唑替尼）获英国NICE推荐，一线治疗ALK阳性肺癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c8c4e5774d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819816, encodeId=c166181981629, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=Ang Chem Int Ed：新型非金属反应系统或可帮助科学家开发出靶向抗癌新药, objectType=article, longId=37614, objectId=48b43e6143d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48b43e6143d, replyNumber=0, likeNumber=83, createdTime=2014-11-16, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48b43e6143d, moduleTitle=Ang Chem Int Ed：新型非金属反应系统或可帮助科学家开发出靶向抗癌新药, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=48b43e6143d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819815, encodeId=8ef818198152a, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=eLife: 生物信息学显示两药联合靶向抗癌可能提高疗效, objectType=article, longId=21917, objectId=0ec32191e4a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ec32191e4a, replyNumber=0, likeNumber=72, createdTime=2014-01-13, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ec32191e4a, moduleTitle=eLife: 生物信息学显示两药联合靶向抗癌可能提高疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0ec32191e4a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819812, encodeId=84ce1819812f4, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=JCO：荟萃分析靶向抗癌药物的致命性不良反应事件, objectType=article, longId=4018, objectId=c86a40184d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c86a40184d, replyNumber=0, likeNumber=59, createdTime=2012-10-10, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c86a40184d, moduleTitle=JCO：荟萃分析靶向抗癌药物的致命性不良反应事件, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c86a40184d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819814, encodeId=725a1819814ee, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=第10届国际靶向抗癌治疗大会在阿姆斯特丹召开, objectType=article, longId=4299, objectId=61b6429988, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61b6429988, replyNumber=0, likeNumber=77, createdTime=2012-07-07, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61b6429988, moduleTitle=第10届国际靶向抗癌治疗大会在阿姆斯特丹召开, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=61b6429988)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819811, encodeId=c77c18198113f, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=靶向抗癌治疗方法(斯坦福大学公开课), objectType=article, longId=3629, objectId=09ed3629a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09ed3629a2, replyNumber=0, likeNumber=88, createdTime=2012-01-14, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09ed3629a2, moduleTitle=靶向抗癌治疗方法(斯坦福大学公开课), moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=09ed3629a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819813, encodeId=10d118198139a, content=<a href='/topic/show?id=9ec7999104d' target=_blank style='color:#2F92EE;'>#靶向抗癌#</a>, objectTitle=全球有79种靶向抗癌药物正在临床研发中, objectType=article, longId=4203, objectId=eb8a420341, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb8a420341, replyNumber=0, likeNumber=92, createdTime=2012-10-20, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb8a420341, moduleTitle=全球有79种靶向抗癌药物正在临床研发中, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=eb8a420341)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

靶向抗癌

2020-05-29

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

Transl Res：王慧和刘宁宁团队发现靶向抗癌药物能增强抗真菌作用

2022-11-20

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

National Science Review ：突破 | 刘红科/赵劲/郭子建提出的新策略成功实现了肿瘤内制造靶向抗癌药物

2021-11-07

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

诺华的新型口服CDK4/6靶向抗癌药Kisqali喜获NICE推荐，用作二线治疗晚期乳腺癌

2019-10-27

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

JAMA Oncol：靶向抗癌药究竟对哪些癌症患者有效，一测便知！

2018-08-22

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

J Am Acad Dermatol：使用靶向抗癌药物能促进患者的色素改变（Meta分析）

2018-07-19

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

肝癌福音！美国FDA授予拜耳靶向抗癌药Stivarga优先审查资格，二线治疗晚期肝细胞癌

2017-12-05

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

重磅！诺华新型靶向抗癌药Zykadia一线治疗晚期ALK+肺癌III期临床获得成功，辉瑞霸主地位将不保

2017-01-30

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

精准医疗典范：欧盟批准辉瑞靶向抗癌药Xalkori治疗ROS1阳性非小细胞肺癌（NSCLC）

2016-11-12

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

喜讯！辉瑞口服靶向抗癌药Xalkori（克唑替尼）获英国NICE推荐，一线治疗ALK阳性肺癌

2017-03-24

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

Ang Chem Int Ed：新型非金属反应系统或可帮助科学家开发出靶向抗癌新药

2014-11-16

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

eLife: 生物信息学显示两药联合靶向抗癌可能提高疗效

2014-01-13

仁心济世 (审核中...)

前往app查看评论内容

#靶向抗癌#

JCO：荟萃分析靶向抗癌药物的致命性不良反应事件

2012-10-10

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

第10届国际靶向抗癌治疗大会在阿姆斯特丹召开

2012-07-07

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

靶向抗癌治疗方法(斯坦福大学公开课)

2012-01-14

lqvr (审核中...)

前往app查看评论内容

#靶向抗癌#

全球有79种靶向抗癌药物正在临床研发中

2012-10-20

科室
- - 订阅+
  - 更多科室
工具
服务